- Who we areWho we are
Novavax is a global biotechnology company with a proven vaccine technology. We are focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health.
Discover our scienceLearn about our validated protein-based nanoparticle and Matrix-M™ adjuvant technology.
- What we doWhat we do
Novavax is focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships
Latest UpdatesStay current with Novavax news as we make progress in discovering and developing innovative vaccines to help protect against serious infectious diseases.
- Blog
UPDATE -- Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2016
Management will host a conference call to discuss the quarterly financial results and provide an update on corporate activities. Please be sure to join the webcast in order to access the slide presentation.
Conference call details are as follows:
Date: | Wednesday, November 9, 2016 |
Time: | 4:30 p.m. U.S. Eastern Time (ET) |
Dial-in number: | (877) 212-6076 (Domestic) or (707) 287-9331 (International) |
Passcode: | 10126707 |
Webcast: | www.novavax.com, “Investors”/ “Events” |
|
|
Conference call replay:
Dates: | Starting at 8:30 p.m. ET, November 9, 2016 until November 16, 2016 |
Dial-in number: | (855) 859-2056 (Domestic) or (404) 537-3406 (International) |
Passcode: | 10126707 |
Webcast: | www.novavax.com, “Investors”/ “Events” |
|
|
About
Contact:
SVP, Chief Financial Officer and Treasurer
Associate Director, Investor Relations
[email protected]
240-268-2000
